全文获取类型
收费全文 | 21569篇 |
免费 | 3718篇 |
国内免费 | 263篇 |
专业分类
耳鼻咽喉 | 768篇 |
儿科学 | 891篇 |
妇产科学 | 526篇 |
基础医学 | 1898篇 |
口腔科学 | 541篇 |
临床医学 | 2706篇 |
内科学 | 4960篇 |
皮肤病学 | 640篇 |
神经病学 | 2153篇 |
特种医学 | 898篇 |
外科学 | 5038篇 |
综合类 | 186篇 |
现状与发展 | 2篇 |
一般理论 | 3篇 |
预防医学 | 1553篇 |
眼科学 | 570篇 |
药学 | 554篇 |
中国医学 | 12篇 |
肿瘤学 | 1651篇 |
出版年
2023年 | 538篇 |
2022年 | 194篇 |
2021年 | 395篇 |
2020年 | 792篇 |
2019年 | 314篇 |
2018年 | 791篇 |
2017年 | 738篇 |
2016年 | 890篇 |
2015年 | 824篇 |
2014年 | 1162篇 |
2013年 | 1355篇 |
2012年 | 731篇 |
2011年 | 687篇 |
2010年 | 865篇 |
2009年 | 1063篇 |
2008年 | 736篇 |
2007年 | 576篇 |
2006年 | 669篇 |
2005年 | 619篇 |
2004年 | 544篇 |
2003年 | 461篇 |
2002年 | 475篇 |
2001年 | 537篇 |
2000年 | 460篇 |
1999年 | 474篇 |
1998年 | 374篇 |
1997年 | 385篇 |
1996年 | 428篇 |
1995年 | 391篇 |
1994年 | 263篇 |
1993年 | 210篇 |
1992年 | 415篇 |
1991年 | 403篇 |
1990年 | 354篇 |
1989年 | 424篇 |
1988年 | 375篇 |
1987年 | 361篇 |
1986年 | 354篇 |
1985年 | 339篇 |
1984年 | 260篇 |
1983年 | 262篇 |
1982年 | 197篇 |
1981年 | 174篇 |
1980年 | 170篇 |
1979年 | 250篇 |
1978年 | 238篇 |
1977年 | 193篇 |
1976年 | 194篇 |
1975年 | 185篇 |
1972年 | 181篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Marcie L. Rabin MD Claire Stevens‐Haas Emilyrose Havrilla Tanvi Devi BS Roger Kurlan MD 《Movement disorders》2014,29(2):177-183
The field of women's health developed based on the recognition that there are important sex‐based differences regarding several aspects of medical illnesses. We performed a literature review to obtain information about differences between women and men for neurological movement disorders. We identified important differences in prevalence, genetics, clinical expression, course, and treatment responses. In addition, we found that female life events, including menstruation, pregnancy, breast feeding, menopause, and medications prescribed to women (such as oral contraceptives and hormone‐replacement therapy), have significant implications for women with movement disorders. Understanding this biological sex‐specific information can help improve the quality and individualization of care for women with movement disorders and may provide insights into neurobiological mechanisms. © 2013 International Parkinson and Movement Disorder Society 相似文献
992.
993.
Ashwini K. Rao EdD OTR Karen S. Marder MD MPH Jasim Uddin BS Brian C. Rakitin PhD 《Movement disorders》2014,29(12):1516-1522
In Huntington's disease (HD), increased variability is seen in performance of motor tasks that require implicit control of timing. We examined whether timing variability was also evident in an explicit interval‐timing task. Sixty subjects (21 controls, 19 manifest HD, and 20 pre‐manifest HD) performed a single‐interval production task with three target intervals (1.1 s, 2.2 s, 3.3 s). We analyzed accuracy (proportional error) and precision (standard deviation) across groups and intervals. No differences were seen in accuracy across groups or intervals. Precision was significantly lower in manifest (P = 0.0001) and pre‐manifest HD (P = 0.04) compared with controls. This was particularly true for pre‐manifest subjects close to diagnosis (based on probability of diagnosis in 5 years). Precision was correlated with proximity to diagnosis (r2 = 0.3, P < 0.01). To examine the source of reduced precision, we conducted linear regression of standard deviation with interval duration. Slope of the regression was significantly higher in manifest HD (P = 0.02) and in pre‐manifest HD close to diagnosis (P = 0.04) compared with controls and pre‐manifest participants far from diagnosis. Timing precision is impaired before clinical diagnosis in Huntington's disease. Slope analysis suggests that timing variability (decreased precision) was attributable to deficits in timing‐dependent processes. Our results provide additional support for the proposal that the basal ganglia are implicated in central timekeeping functions. Because the single interval production task was sensitive to deficits in pre‐manifest HD, temporal precision may be a useful outcome measure in future clinical trials. © 2014 International Parkinson and Movement Disorder Society 相似文献
994.
Pierre‐Antoine Gourraud PhD Roland G. Henry PhD Bruce A. C. Cree MD PhD MAS Jason C. Crane PhD Antoine Lizee MS Marram P. Olson BS Adam V. Santaniello BSc Esha Datta MS Alyssa H. Zhu MSc Carolyn J. Bevan MD MS Jeffrey M. Gelfand MD MAS Jennifer S. Graves MD PhD Douglas S. Goodin MD Ari J. Green MD MCR H.‐Christian von Büdingen MD Emmanuelle Waubant MD PhD Scott S. Zamvil MD PhD Elizabeth Crabtree‐Hartman MD Sarah Nelson PhD Sergio E. Baranzini PhD Stephen L. Hauser MD 《Annals of neurology》2014,76(5):633-642
We present a precision medicine application developed for multiple sclerosis (MS): the MS BioScreen. This new tool addresses the challenges of dynamic management of a complex chronic disease; the interaction of clinicians and patients with such a tool illustrates the extent to which translational digital medicine—that is, the application of information technology to medicine—has the potential to radically transform medical practice. We introduce 3 key evolutionary phases in displaying data to health care providers, patients, and researchers: visualization (accessing data), contextualization (understanding the data), and actionable interpretation (real‐time use of the data to assist decision making). Together, these form the stepping stones that are expected to accelerate standardization of data across platforms, promote evidence‐based medicine, support shared decision making, and ultimately lead to improved outcomes. Ann Neurol 2014;76:633–642 相似文献
995.
996.
997.
Elisabetta Soragni PhD Wenyan Miao PhD Marco Iudicello MD David Jacoby MD Stefania De Mercanti MD Marinella Clerico MD Filomena Longo MD Antonio Piga MD Sherman Ku PhD Erica Campau BS Jintang Du PhD Pablo Penalver PhD Myriam Rai PhD Joseph C. Madara PhD Kristopher Nazor PhD Melinda O'Connor PhD Anton Maximov PhD Jeanne F. Loring PhD Massimo Pandolfo MD Luca Durelli MD Joel M. Gottesfeld PhD James R. Rusche PhD 《Annals of neurology》2014,76(4):489-508
998.
Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual‐energy x‐ray absorptiometry 下载免费PDF全文
999.
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells 下载免费PDF全文
Curtis R. Pickering PhD Mitchell J. Frederick PhD Genevieve A. Andrews MD Samar A. Jasser PhD David R. Fooshee BS Zvonimir L. Milas MD Chad Galer MD Daisuke Sano MD PhD William N. William MD Jr Edward Kim MD John Heymach MD PhD Lauren A. Byers MD Vali Papadimitrakopoulou MD Jeffrey N. Myers MD PhD 《Head & neck》2014,36(11):1547-1554
1000.
Marvin Heyboer III MD William D. Grant EDD Joseph Byrne MD Paula Pons MD Monica Morgan MD Bilal Iqbal BS Susan M. Wojcik PhD 《Wound repair and regeneration》2014,22(3):351-355
There is limited data regarding hyperbaric oxygen's effectiveness in the treatment of nonhealing arterial insufficiency ulcers. This study was designed to analyze healing rates and amputation rates in patients who underwent adjunctive hyperbaric oxygen for a nonhealing arterial insufficiency ulcer. A retrospective chart review was completed on patients who underwent hyperbaric oxygen for arterial insufficiency ulcers that failed to heal despite standard treatment. Information collected included complete ulcer healing, amputation, and patient characteristics. There were 82 patients identified. A majority did not have diabetes (84.1%). The overall rate of healing was 43.9%. The overall major amputation rate was 17.1%. The amputation rate among those who healed was 0% compared to 42.4% among those not healed (p < 0.0001). Dialysis was predictive of major amputation (p = 0.03). Our findings suggest hyperbaric oxygen can play a role in management of arterial insufficiency ulcers that have failed standard treatment. The overwhelming majority of these patients did not have diabetes, which allows this study to be translated to patients with a primary arterial insufficiency ulcer. These results support the use of hyperbaric oxygen for select nonhealing arterial insufficiency ulcers that have failed standard therapy and the need for a prospective pilot study. 相似文献